Argus Investors Counsel Inc. reduced its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 11.4% in the second quarter, Holdings Channel reports. The firm owned 5,796 shares of the healthcare product maker’s stock after selling 745 shares during the period. Argus Investors Counsel Inc.’s holdings in Abbott Laboratories were worth $788,000 at [...]
Argus Investors Counsel Inc. Reduces Holdings in Abbott Laboratories $ABT
